| 65.80 Real-Time Quote |  -1.81 / -2.68%Today’s Change | 42.12 Today|||52-Week Range 69.65 | +23.17% Year-to-Date |
| Positive Data on Bayer Candidate - Analyst Blog May 23 / Zacks.com | Bayer Files Riociguat in Japan - Analyst Blog May 21 / Zacks.com |
| United Reaches New 52-Week High (UTHR) May 22 / TheStreet.com |
| Previous close | 67.61 |
| Today’s open | 67.58 |
| Day’s range | 65.25 - 67.58 |
| Volume | 333,323 |
| Average volume (3 months) | 835,537 |
| Market cap | $3.4B |
| Dividend yield | -- |
| Earnings growth (last year) | +56.12% |
| Earnings growth (this year) | +3.59% |
| Earnings growth (next 5 years) | +18.00% |
| Revenue growth (last year) | +22.99% |
| P/E ratio | 11.7 |
| Price/Sales | 3.04 |
| Price/Book | 3.13 |
| Today’s change | Today’s % change | |
|---|---|---|
| THRXTheravance Inc | -0.54 | -1.47% |
| SLXPSalix Pharmaceutical... | +0.48 | +0.80% |
| INCYIncyte Corp | +0.44 | +1.98% |
| JAZZJazz Pharmaceuticals... | +1.70 | +2.70% |
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | $1.47 |
| Annual revenue (last year) | $914.1M |
| Annual profit (last year) | $304.4M |
| Net profit margin | 33.31% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer Martine A. Rothblatt, PhD, MBA |
President, Chief Operating Officer & Director Roger Jeffs, PhD |
Corporate headquarters Silver Spring, Maryland |
.
